Sélection de la langue

Gouvernement du Canada / Government of Canada

Recherche

ARCHIVÉ - Références

Nous avons archivé cette page et elle ne sera plus mise à jour.

Ce numéro du RMTC est archivé. Son contenu est toujours pertinent aux fins de recherche et de consultation.

Nous avons archivé cette page et elle ne sera plus mise à jour.

Vous pouvez la consulter à des fins de recherche ou à titre de référence.

 

  1. Demers B, Simor AE, Vellend H et al. Severe invasive group A streptococcal infections in Ontario, Canada: 1987-1991. Clin Infect Dis 1993;16:792-800.
  2. Efstratiou A. Group A streptococci in the 1990s. J Antimicrob Chemother 2000;45:3-12.
  3. Eriksson KG, Andersson J, Holm SE et al. Epidemiological and clinical aspects of invasive group A streptococcal infections and the streptococcal toxic shock syndrome. Clin Infect Dis 1998;27:1428-36.
  4. Stevens DL. Invasive group A streptococcal infections: The past, present and future.Pediatr Infect Dis J 1994;13:561-6.
  5. Hoge CW, Schwartz B, Talkington DF et al. The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome. JAMA 1993;269:384-9.
  6. Schwartz B, Facklam RR, Breiman RF. Changing epidemiology of group A streptococcal infection in the USA. Lancet 1990;336:1167-71.
  7. 7. Bisno AL, Stevens DL. Streptococcus pyogenes (including streptococcal toxic shock syndrome and necrotizing fasciitis). In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases,5th ed. Philadelphia: Churchill Livingstone, 2000:2101-17.
  8. Santé Canada. Sommaire annuel des maladies à déclaration obligatoire : 2001.RMTC 2004;30S3:92-4.
  9. International Circumpolar Surveillance (ICS) summary report: Year 2000 data. Anchorage: International Circumpolar Surveillance, 2002.
  10. International Circumpolar Surveillance (ICS) summary report: Year 2001 data. Anchorage: International Circumpolar Surveillance, 2003.
  11. International Circumpolar Surveillance (ICS) summary report: Year 2002 data. Anchorage: International Circumpolar Surveillance, 2005.
  12. International Circumpolar Surveillance (ICS) preliminary summary report: Year 2003 data. Anchorage: International Circumpolar Surveillance, 2005.
  13. Tyrrell GJ, Lovgren M, Forwick B et al. M types of group A streptococcal isolates submitted to the Centre national pour le streptocoque (Canada) from 1993 to 1999. J Clin Microbiol 2002;40:4466-71.
  14. Annual report for April 1, 2002 to March 31, 2003. Edmonton: Centre national pour le streptocoque, 2003.
  15. Annual report for April 1, 2003 to March 31, 2004. Edmonton: Centre national pour le streptocoque, 2004.
  16. Annual report for April 1, 2004 to March 31, 2005. Edmonton: Centre national pour le streptocoque, 2005.
  17. Davies HD, McGeer A, Schwartz B et al. Invasive group A streptococcal infections in Ontario, Canada. N Engl J Med 1996;335:547-54.
  18. Sharkawy A, Low DE, Saginur R et al. Severe group A streptococcal soft-tissue infections in Ontario: 1992-1996. Clin Infect Dis 2002;34:454-60.
  19. Muller MP, Low DE, Green KA et al. Clinical and epidemiologic features of group A streptococcal pneumonia in Ontario, Canada. Arch Intern Med 2003;163:467-72.
  20. Tyrrell GJ, Lovgren M, Kress B et al. Invasive group A streptococcal disease in Alberta, Canada (2000 to 2002). J Clin Microbiol 2005;43:1678-83.
  21. Santé Canada. Définitions de cas des maladies faisant l'objet d'une surveillance nationale.RMTC 2000;26S3:1-134.
  22. Robinson KA, Rothrock G, Phan Q et al. Risk for severe group A streptococcal disease among patients' household contacts. Emerg Infect Dis 2003;9:443-7.
  23. Schwartz B, Elliott JA, Butler JC et al. Clusters of invasive group A streptococcal infections in family, hospital, and nursing home settings. Clin Infect Dis 1992;15:277-84.
  24. Davies HD. Invasive group A streptococcal infections: Canadian Pediatric Society Position Statement. Pediatr Child Health 1999;4:73-5. URL: <http://www.cps.ca/english/statements/ID/ id98-05.htm>.
  25. American Academy of Pediatrics. Red book: 2003 report of the Committee on Infectious Diseases, 26th ed. Elk Grove Village, IL: American Academy of Pediatrics, 2003.
  26. Guidelines for the treatment of necrotizing fasciitis (NF) and streptococcal toxic shock syndrome (STSS). Toronto: Ontario Group A Streptococcal Study, 1998. URL: <http://microbiology. mtsinai.on.ca/protocols/pdf/k5a.pdf>.
  27. Prevention of Invasive Group A Streptococcal Infections Working Group. Prevention of invasive group A streptococcal disease among household contacts of case patients and among postpartum and postsurgical patients: Recommendations from the Centers for Disease Control and Prevention. Clin Infect Dis 2002;35:950-9.
  28. Health Protection Agency, Group A Streptococcus Working Group. Interim UK guidelines for management of close community contacts of invasive group A streptococcal disease. Commun Dis Public Health 2004;7:354-61.
  29. Valenzuela TD, Hooton TM, Kaplan EL et al. Transmission of toxic strep syndrome from an infected child to a firefighter during CPR. Annals Emerg Med 1991;20:90-2.
  30. Bohlen LM, Muhlemann K, Dubuis O et al. Outbreak among drug users caused by a clonal strain of group A streptococcus. Emerg Infect Dis 2000;6:175-9.
  31. Lechot P, Schaad HJ, Graf S et al. Group A streptococcus clones causing reported epidemics and endemic disease in intravenous drug users. Scand J Infect Dis 2001;33:41-6.
  32. Brunner S, Fleisch F, Ruef C et al. Automated ribotyping and pulsed-field gel electrophoresis reveal a cluster of group A streptococci in intravenous drug abusers. Infection 2000;28:314-7.
  33. Smolyakov R, Riesenberg K, Schlaeffer F et al. Streptococcal septic arthritis and necrotizing fasciitis in an intravenous drug users couple sharing needles. Isr Med Assoc J 2002;4:302-3.
  34. Weiss K, Laverdiere M, Lovgren M et al. Group A streptococcus carriage among close contacts of patients with invasive infections. Am J Epidemiol 1999;149:863-8.
  35. Smith A, Li A, Tolomeo O et al. Mass antibiotic treatment for group A streptococcus outbreaks in two long-term care facilities. Emerg Infect Dis 2003;9:1260-5.
  36. Hansen JL, Paulissen JP, Larson AL et al. Nursing home outbreaks of invasive group A streptococcal infections - Illinois, Kansas, North Carolina and Texas. MMWR 1990;39:577-9.
  37. Barry MA, Matthew K, Tormey P et al. Outbreak of invasive group A streptococcus associated with varicella in a childcare center -Boston, Massachusetts, 1997. MMWR 2004;46:944-8.
  38. Falck G, Kjellander J. Outbreak of group A streptococcal infection in a day-care center. Pediatr Infect Dis J 1992;11:914-9.
  39. Engelgau MM, Woernle CH, Schwartz B et al. Invasive group A streptococcus carriage in a child care centre after a fatal case. Arch Dis Child 1994;71:318-22.
  40. Husain E, Bigham M, Davies D et coll. Infection invasive à streptocoque du groupe A chez un frère et une soeur : cas plaidant en faveur de la prophylaxie antibiotique chez les contacts étroits. RMTC 2001;27:141-6.
  41. Ruben FL, Norden CW, Heisler B et al. An outbreak of Streptococcus pyogenes infections in a nursing home.Ann Intern Med 1984;101:494-6.
  42. Harkness GA, Bentley DW, Mottley M et al. Streptococcus pyogenes outbreak in a long-term care facility. Am J Infect Control 1992;20:142-8.
  43. Auerbach SB, Schwartz B, Williams D et al. Outbreak of invasive group A streptococcal infections in a nursing home. Lessons on prevention and control.ArchInternMed 1992;152:1017-22.
  44. Reid RI, Briggs RS, Seal DV et al. Virulent Streptococcus pyogenes: outbreak and spread within a geriatric unit. J Infect 1983;6:219-25.
  45. Barnham M, Hunter S, Hanratty B et al. Invasive M-type 3 Streptococcus pyogenes affecting a family and a residential home. Commun Dis Public Health 2001;4:64-7.
  46. Greene CM, Van Beneden CA, Javadi M et al. Cluster of deaths from group A streptococcus in a long-term care facility - Georgia, 2001. Am J Infect Control 2005;33:108-13.
  47. Brogan TV, Nizet V, Waldhausen JH et al. Group A streptococcal necrotizing fasciitis complicating primary varicella: A series of fourteen patients. Pediatr Infect Dis J 1995;14:588-94.
  48. Wilson GJ, Talkington DF, Gruber W et al. Group A streptococcal necrotizing fasciitis following varicella in children: Case reports and review. Clin Infect Dis 1995;20:1333-8.
  49. Galanis E, Skotniski E, Panaro L et coll. Enquête sur une éclosion de varicelle compliquée par une infection à streptocoque du groupe A dans des collectivités des Premières nations, Zone de Sioux Lookout (Ontario). RMTC 2002;28:157-63.
  50. Laupland KB, Davies HD, Low DE et al. Invasive group A streptococcal disease in children and association with varicella-zoster virus infection. Pediatrics 2000;105:e60-e67.
  51. Hollm-Delgado M-G, Allard R, Pillon PA. Invasive group A streptococcal infections, clinical manifestations and their predictors, Montreal, 1995-2001. Emerg Infect Dis 2005;11:77-82.
  52. Tyrell GJ, Lovgren M, Kress B et al. Varicella-associated invasive group A streptococcal disease in Alberta, Canada - 2000-2002. Clin Infect Dis 2005;40:1055-7.
  53. Comité consultatif national de l'immunisation (CCNI). Mise à jour sur la varicella. RMTC 2004;30(DCC-1):1-27.
  54. Peterson CL, Vugia DJ, Meyers HB et al. Risk factors for invasive group A streptococcal infections in children with varicella: A case-control study. Pediatr Infect Dis J 1996;15:151-6.
  55. Well being: A guide to promote the physical health, safety and emotional well-being of children in child care centres and family day care homes. Ottawa: Canadian Pediatric Society, 1996.
  56. Shulman ST, Gerber MA. So what's wrong with penicillin for strep throat? Pediatrics 2004;113:1816-9.
  57. Casey JR, Pichichero ME. Meta-analysis of cephalosporins versus penicillin for treatment of group A streptococcal tonsillopharyngitis in adults. Clin Infect Dis 2004;38:1526-34.
  58. Gerber MA, Tanz RR, Kabat W et al. Potential mechanisms for failure to eradicate group A streptococci from the pharynx. Pediatrics 1999;104:911-7.
  59. Bisno AL. Are cephalosporins superior to penicillin for treatment of acute streptococcal pharyngitis? Clin Infect Dis 2004;38:1535-7.
  60. Casey JR, Pichichero ME. Meta-analysis of cephalosporins versus penicillin for treatment of group A streptococcal tonsillopharyngitis in children. Pediatrics 2004;113:866-82.
  61. Bisno AL, Gerber MA, Gwaltney JM et al. Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Clin Infect Dis 2002;35:113-25.
  62. Canadian Pediatric Society. Treatment of group A streptococcal pharyngitis. Can J Infect Dis 1997;8:17-8.
  63. Syrogiannopoulos GA, Bozdogan B, Grivea IN et al. Two dosages of clarithromycin for five days, amoxicillin/clavulanate for five days or penicillin V for ten days in acute group A streptococcal tonsillopharyngitis. Pediatr Infect Dis J 2004;23:857-65.
  64. Kafetzis DA, Liapi G, Tsolia M et al. Failure to eradicate group A beta-haemolytic streptococci (GABHS) from the upper respiratory tract after antibiotic treatment. Int J Antimicrob Agents 2004;23:67-71.
  65. Takker U, Dzyublyk O, Busman T et al. Comparison of 5 days of extended-release clarithromycin versus 10 days of penicillin V for the treatment of streptococcal pharyngitis/ tonsillitis: Results of a multicenter, double-blind, randomized study in adolescent and adult patients. Curr Med Res Opin 2003;19:421-9.
  66. Portier H, Filipecki J, Weber P et al. Five day clarithromycin modified release versus 10 day penicillin V for group A streptococcal pharyngitis: A multi-centre, open-label, randomized study. J Antimicrob Chemother 2002;49:337-44.
  67. McCarty J, Hedrick JA, Gooch WM. Clarithromycin suspension vs penicillin V suspension in children with streptococcal pharyngitis. Adv Ther 2000;17:14-26.
  68. Tanz RR, Poncher JR, Corydon KE et al. Clindamycin treatment of chronic pharyngeal carriage of group A streptococci. JPediatr 1991;119:123-8.
  69. Gallegos B, Rios A, Espidel A et al. A double-blind, multicenter comparative study of two regimens of clindamycin hydrochloride in the treatment of patients with acute streptococcal tonsillitis/pharyngitis. Clin Ther 1995;17:613-21.
  70. Schaad UB. Acute streptococcal tonsillopharyngitis: A review of clinical efficacy and bacteriological eradication. J Int Med Res 2004;32:1-13.
  71. Kaplan EL, Johnson DR. Unexplained reduced microbiological efficacy of intramuscular benzathine penicillin G and of oral penicillin V in eradication of group A streptococci from children with acute pharyngitis. Pediatrics 2001;108:1180-6.
  72. Kuhn SM, Preiksaitis J, Tyrell GJ et al. Evaluation of potential factors contributing to microbiological treatment failure in Streptococcus pyogenes pharyngitis. Can J Infect Dis 2001;12:33-9.
  73. Kaplan EL, Gastanaduy AS, Huwe BB. The role of the carrier in treatment failures after antibiotic for group A streptococci in the upper respiratory tract. J Lab Clin Med 1981;98:326-35.
  74. Sela S, Neeman R, Keller N et al. Relationship between asymptomatic carriage of Streptococcus pyogenes and the ability of the strains to adhere to and be internalised by cultured epithelial cells. J Med Microbiol 2000;49:499-502.
  75. Cohen R. Defining the optimum treatment regimen for azithromycin in acute tonsillopharyngitis. Pediatr Infect Dis J 2004;23:S129-S134.
  76. Vanderkooi OG, Low DE, Green K et al. Predicting antimicrobial resistance in invasive pneumococcal infections. Clin Infect Dis 2005;40:1288-97.
  77. Kotloff KL, Corretti M, Palmer K et al. Safety and immunogenicity of a recombinant multivalent group A streptococcal vaccine in healthy adults: Phase 1 trial. JAMA 2004;292:709-15.
  78. McNeil SA, Halperin SA, Langley JM et al. Safety and immunogenicity of 26-valent group A streptococcus vaccine in healthy adult volunteers. Clin Infect Dis 2005;41:1114-22.
  79. ID Biomedical announces positive results from phase II clinical trial of Streptavax vaccine. ID Biomedical Corporation, press release, August 10, 2004.
Signaler un problème ou une erreur sur cette page
Veuillez sélectionner toutes les cases qui s'appliquent :

Merci de votre aide!

Vous ne recevrez pas de réponse. Pour toute question, contactez-nous.

Date de modification :